Medtronic's StrataMR adjustable valves and shunts are used in the
management of hydrocephalus or 'water on the brain'.
Cerebrospinal fluid acts as a cushion or buffer for the brain's
cortex, providing basic mechanical and immunological protection to
the brain inside the skull.
The company said it was conducting the voluntary recall due to an
issue that can occur after implantation, potentially leading to
under-drainage of cerebrospinal fluid.
The medical device maker said the affected StrataMR valves and
shunts were manufactured from Oct. 27, 2015 to Nov. 11, 2016.
(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Maju
Samuel)
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |